Allogeneic hematopoietic stem cell transplantation: lessons learned by a molecular immunologist/transplant patient.

[1]  O. Abdel-Wahab,et al.  Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic , 2022, Genes & development.

[2]  J. Kanter,et al.  Gene therapy for sickle cell disease: where we are now? , 2021, Hematology. American Society of Hematology. Education Program.

[3]  R. Soiffer,et al.  HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis. , 2021, Blood.

[4]  M. Scorsetti,et al.  Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia. , 2020, The Lancet. Oncology.

[5]  M. Biernacki,et al.  T cell optimization for graft-versus-leukemia responses. , 2020, JCI insight.

[6]  B. Druker,et al.  Response and Resistance to BCR-ABL1-Targeted Therapies. , 2020, Cancer cell.

[7]  M. Sorror,et al.  Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts , 2020, Annals of Internal Medicine.

[8]  P. Vyas,et al.  The Graft-Versus-Leukemia Effect in AML , 2019, Front. Oncol..

[9]  B. Ebert,et al.  Clonal hematopoiesis in human aging and disease , 2019, Science.

[10]  Xiao-jun Huang,et al.  Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease , 2018, Front. Immunol..

[11]  R. Levine,et al.  Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. , 2018, Cell stem cell.

[12]  A. Marghoob,et al.  A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma , 2018, The British journal of dermatology.

[13]  An Liu,et al.  Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[15]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[16]  J. Dipersio,et al.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. , 2016, Blood.

[17]  N. Majhail,et al.  Racial disparities in hematopoietic cell transplantation in the United States , 2012, Bone Marrow Transplantation.